The promise of successful drug development starts with the sample data value chain.
Sample Data Value Chain: From Site to Result
In recent years, sample management practices have been lead directly to increased quality, speed, and reproducibility of research and development.
Biopharma sponsors have joined forces to pursue standardized and interoperable systems, processes, and ecosystems for connecting the sample data value chain. As a direct result, technology and data is playing and will play a key role for the future of clinical and sample operations.
In his presentation, “From Site to Result: Real-Time Sample Intelligence Unlocked with GenAI,” QuartzBio’s CTO and Co-Founder Tobi Guennel, PhD explores the opportunities for technology to empower the people and processes across the entire sample data value chain, addressing:
- The importance of the sample data value chain in the context of R&D productivity
- Benefits of connecting data across the entire sample data value chain instead of focusing on individual links of the chain
- How a platform approach, leveraging a domain-specific Precision Medicine AI Agent Network, enables seamless data ingestion and real-time sample intelligence across the value chain
Watch the recording of our presentation*:
*Video not showing? Please accept cookies or view video here.
